Bone Biologics (BBLG) Financial Statements

Bone Biologics's market cap is currently $3.05M. The company's EPS TTM is $-4.865; its P/E ratio is -0.25; Bone Biologics is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.